SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Tech Stock Options -- Ignore unavailable to you. Want to Upgrade?


To: Michael Rich who wrote (28740)11/18/1997 2:40:00 PM
From: Kevin  Read Replies (1) | Respond to of 58727
 
Hi Michael. It's great to see you back! Hope you had a fantastic vacation.

>>>Hope you are feeling better now.<<<
Thanks.
Unfortunately, I've been getting worse. Shoulda stayed home today again, but I can't stand being home doing nothing. Matter of fact I was so bored yesterday that I took the fixtures off of the sink in my downstairs bathroon....and the piping below the sink. Supposed to replace all of it was some fancy crap my wife bought, but didn't have time. Yikes! Wait til she uses that bathroom and sees that I didn't finish :-)

Take care.



To: Michael Rich who wrote (28740)11/18/1997 2:46:00 PM
From: Jerry Olson  Read Replies (1) | Respond to of 58727
 
Mikey

Hope you bailed on my e-mail!!!

What are the blocks doin' today??? resting???



To: Michael Rich who wrote (28740)11/18/1997 3:23:00 PM
From: j g cordes  Read Replies (1) | Respond to of 58727
 
Michael, CHIR is dropping, drooping.. whatever, its falling towards its long term support trend. There's an interesting blurb which supports my optimism for a nice trade here (or lower.. even to 16?) from M Murphy... though he's had his head handed to him more than once. Anyway I've quoted it below if you have anything to add from your resources.

"To: Celeryroot (945 )
From: G-MAN
Saturday, Nov 15 1997 1:39PM EST
Reply #946 of 947

To All:

Michael Murphy, editor of the California Technology Stock Letter, seems to think that
Cephalon and Chiron will get approval for Myotrophin by year end or early 1998. He
thinks that Wall Street is discounting the shares of Chiron for the simple reason that the
drug will be ultimately denied approval. It will be interesting to see what happens to the
shares if the drug is approved. (Maybe an investment in Cephalon calls with a Feb to
April expiration date may be an interesting gamble.)

I'm sure that most everyone here either gets the CTSL or the Medical Technology Stock
Letter. Both Murphy and McCamant are table thumpers regarding Chiron for the long
term. Regarding the short term, one has to just wait it out."